Pharma Archives - Page 28 of 80 - Life Sciences Times

Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine

September 23, 2025

Meet the Man Behind FDA-Approved Bladder Cancer Breakthrough: Dr. Purnanand Sarma and the Journey of INLEXZO™

September 22, 2025

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

September 19, 2025

THIS WEEK'S STORIES

Charles River Associates Expands Life Sciences Practice with New Vice President Frances Hendry

September 23, 2025

Ncardia Unveils First iPSC-Derived Non-Human Primate Cardiomyocytes for Cardiac Safety Research

September 23, 2025

xFOREST and Axcelead DDP Launch Joint Research on RNA-Targeted Small Molecule Drug Discovery

September 19, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Actio Biosciences Doses First Participant in Phase 1 Trial of ABS-1230 for KCNT1-Related Epilepsy

FDA Issues Complete Response Letter for Scholar Rock’s Apitegromab, Citing Catalent Facility Observations

Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine

KalVista Wins EU, Swiss Approvals for EKTERLY, First Oral On-Demand Therapy for Hereditary Angioedema

Nuvation Bio Gains Japan Approval for IBTROZI in Advanced ROS1-Positive Lung Cancer

Most Read

Actio Biosciences Doses First Participant in Phase 1 Trial of ABS-1230 for KCNT1-Related Epilepsy

Study Finds Sensus Healthcare’s SRT with Punch Excision Effective for Treating Keloids

Ncardia Unveils First iPSC-Derived Non-Human Primate Cardiomyocytes for Cardiac Safety Research

Altera Names Sandeep Nayyar Chief Financial Officer

EDITOR PICKS

Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine

Meet the Man Behind FDA-Approved Bladder Cancer Breakthrough: Dr. Purnanand Sarma and the Journey of INLEXZO™

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

THIS WEEK'S STORIES

Charles River Associates Expands Life Sciences Practice with New Vice President Frances Hendry

Ncardia Unveils First iPSC-Derived Non-Human Primate Cardiomyocytes for Cardiac Safety Research

xFOREST and Axcelead DDP Launch Joint Research on RNA-Targeted Small Molecule Drug Discovery

POPULAR CATEGORY

ABOUT US

FOLLOW US